Webinar: Unlocking the spatial dimension - Maximizing insights from spatial omics data
On May 29th at 15:00 CEST, join us for an in-depth webinar delving into the cutting-edge realm of spatial omics technologies. Register now!
For just one project at the intersection of data science and biology, you might require expertise spanning from the deep understanding of multi-omics and bioinformatics analysis, to applied skills in software engineering and data architecture and governance. At BioLizard, we’re dedicated to fostering this deep and broad expertise in our team of Lizards - and we’ve collected that knowledge here for you to explore.
Lausanne (Switzerland) and Ghent (Belgium), April 18, 2024 – BioLizard, the bioinformatics, data analytics and data management service and consulting company heading digital transformation in the life sciences industry, today announced the appointment of Matthew Hall, PhD, as Director of Business ...
BioLizard’s custom advanced analytics services complement AbnomX’s innovative, user-friendly platform for deciphering immune repertoire data. GHENT, Belgium April 2nd, 2024 - AbnomX and BioLizard announced a strategic partnership today. AbnomX are pioneers in the industrialization of antibody ...
Thanks to advances in molecular biotechnology techniques, we are producing vast quantities data more quickly than ever before - and that data also drills down to increasingly detailed levels. Naturally, more - and increasingly complex - data brings with it new data analytics challenges. Ensuring ...
No biologist likes a black box. As scientists, we’re skeptical - we want to know why something works, and how something works - not just that it works. And that’s for good reason! Biology, as you know, is very complex, and we’re still only just scraping the surface in terms of understanding how the ...
As we covered in our recent blog series, we expect advances in single cell sequencing to have an important impact on biomedicine. We predict that new technologies and tools like high-throughput single cell sequencing, spatial technologies, and increased public availability of data atlases will ...
Artificial Intelligence (AI) is swiftly becoming a cornerstone technology in the early stages of drug discovery and preclinical development. We're witnessing an increasing number of AI-driven breakthroughs in this field… right? Let’s take a critical look together.